{
    "2021-06-10": [
        [
            {
                "time": "",
                "original_text": "华熙生物樊媛：品类创新的背后是什么？｜消研所沙龙",
                "features": {
                    "keywords": [
                        "华熙生物",
                        "品类创新",
                        "消研所沙龙"
                    ],
                    "sentiment_score": 0.6,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "生物科技",
                        "消费品"
                    ],
                    "causal_factor": "false",
                    "causal_impact": "",
                    "affected_by_time_series": "false",
                    "ts_effect_direction": ""
                }
            },
            {
                "time": "",
                "original_text": "华熙生物现16笔大宗交易 共成交32,815.10万元",
                "features": {
                    "keywords": [
                        "华熙生物",
                        "大宗交易",
                        "成交额"
                    ],
                    "sentiment_score": 0.7,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "生物科技"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "",
                "original_text": "医美股集体暴跌背后：减持大幕开启 朗姿股份领跌 企业无心恋战高位套现 连续下跌",
                "features": {
                    "keywords": [
                        "医美股",
                        "暴跌",
                        "减持",
                        "朗姿股份"
                    ],
                    "sentiment_score": -0.9,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "医美"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "negative",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "negative"
                }
            },
            {
                "time": "",
                "original_text": "国盛证券--医美行业2021中期策略：科技变美，服务赋能【行业研究】",
                "features": {
                    "keywords": [
                        "国盛证券",
                        "医美行业",
                        "中期策略",
                        "科技变美",
                        "服务赋能"
                    ],
                    "sentiment_score": 0.8,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "医美"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "false",
                    "ts_effect_direction": ""
                }
            },
            {
                "time": "",
                "original_text": "科创板行情下机构投资新风向：前期超跌引掘金，布局未来核心资产",
                "features": {
                    "keywords": [
                        "科创板",
                        "机构投资",
                        "超跌",
                        "核心资产"
                    ],
                    "sentiment_score": 0.7,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "科技",
                        "金融"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "",
                "original_text": "朗姿股份：一致行动人拟清仓减持 医美业务去年贡献约三成营收 拟减持股份",
                "features": {
                    "keywords": [
                        "朗姿股份",
                        "清仓减持",
                        "医美业务",
                        "营收",
                        "减持"
                    ],
                    "sentiment_score": -0.8,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "医美"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "negative",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "negative"
                }
            }
        ]
    ]
}